We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

altona Diagnostics GmbH

altona Diagnostics GmbH develops and commercializes real-time PCR based assays and molecular diagnostic test solution... read more Featured Products: More products

Download Mobile App




Multiplex PCR Test Identifies Seven STI Pathogens in One Hour

By LabMedica International staff writers
Posted on 02 Jul 2026

Sexually transmitted infections (STIs) continue to rise, increasing demand for rapid, accurate detection of multiple pathogens across varied sample types. More...

To support flexible, standardized testing, a new IVDR-compliant multiplex PCR system offers customizable detection of up to seven STI pathogens with about a one-hour run time.

Altona Diagnostics (Hamburg, Germany) announced its FlexStar STI Panel has obtained CE marking under Regulation (EU) 2017/746, completing the company’s transition of its modular STI portfolio to the IVDR framework. The panel supports qualitative detection and differentiation of up to seven pathogens in a single sample: Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), Trichomonas vaginalis (TV), Ureaplasma urealyticum (UU), Ureaplasma parvum (UP), and Mycoplasma hominis (MH). The design allows laboratories to configure the combination of targets according to clinical needs or guidelines.

The FlexStar approach uses adaptive multiplex PCR with a single amplification mix and interchangeable detection modules, such as CT/NG, MG/UU/TV, and UP/MH. The assay is validated for urine and genital swab specimens and integrates into the AltoStar Molecular Diagnostic Workflow from sample preparation through detection and analysis. Following sample preparation, the workflow delivers PCR results in about one hour.

CE marking in accordance with the IVDR demonstrates conformity with safety, performance, and clinical evidence requirements for the product. Alignment with AltoStar instrumentation and software is intended to standardize processing, increase throughput efficiency, and simplify routine operations. The optional AltoStar Analysis software can automate PCR result interpretation to reduce hands-on time, standardize review, and support reproducible, traceable reporting.

“With the launch of our first CE marked FlexStar® panel, we are entering the field of syndromic testing with flexible, compliant diagnostics designed to meet the evolving needs of modern laboratory workflows,” said Dr. Sönke Friedrichsen, General Manager of altona Diagnostics.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.